120 related articles for article (PubMed ID: 17201125)
1. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
[TBL] [Abstract][Full Text] [Related]
2. Vessel dilator and kaliuretic peptide inhibit ERK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(5A):3217-22. PubMed ID: 17094432
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
[TBL] [Abstract][Full Text] [Related]
4. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(6B):3813-8. PubMed ID: 18225537
[TBL] [Abstract][Full Text] [Related]
6. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Skelton WP; Lenz A; Wang H; Vesely DL
Anticancer Res; 2009 Apr; 29(4):971-5. PubMed ID: 19414334
[TBL] [Abstract][Full Text] [Related]
7. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
[TBL] [Abstract][Full Text] [Related]
8. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
[TBL] [Abstract][Full Text] [Related]
9. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
Bell EN; Tse MY; Frederiksen LJ; Gardhouse A; Pang SC; Graham CH; Siemens DR
J Urol; 2007 Feb; 177(2):751-6. PubMed ID: 17222675
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides up-regulate aquaporin 3 in a human colonic epithelial cell line.
Itoh A; Tsujikawa T; Yasuoka T; Nakahara T; Sasaki M; Fujiyama Y
Int J Mol Med; 2004 Oct; 14(4):621-6. PubMed ID: 15375592
[TBL] [Abstract][Full Text] [Related]
14. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Vesely DL; Perez-Lamboy GI; Schocken DD
Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
[TBL] [Abstract][Full Text] [Related]
15. The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.
Borán MS; Baltrons MA; García A
Glia; 2008 Mar; 56(4):394-411. PubMed ID: 18186083
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
[TBL] [Abstract][Full Text] [Related]
17. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
[TBL] [Abstract][Full Text] [Related]
19. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
